TanujaChitnisMD

Neurology • Boston, MA

Professor of Neurology, Harvard Medical School, Mass General and Brigham and Women's Hospital

Join to view full profile

Dr. Chitnis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chitnis' full profile

Already have an account?

Office
60 Fenwood Road, 1B
Neurology
Boston, MA 02115
Phone+1 617-525-6550

Fax+1 617-525-6554

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 1995 - 1998
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1994 - 1995
University of Toronto Faculty of MedicineClass of 1994

Certifications & Licensure

MA State Medical License 1999 - 2026
NH State Medical License 2023 - 2025
ME State Medical License 2021 - 2024
RI State Medical License 2021 - 2024
PA State Medical License 1995 - 1998
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
Completed
Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS Start of enrollment: 2015 May 01
Withdrawn

Publications & Presentations

PubMed

323 citations
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot
The Lancet. Neurology. 2023-03-01
16 citations
Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort.
Giovanna S Manzano, Rebecca Salky, Farrah J Mateen, Eric C Klawiter, Tanuja Chitnis
Frontiers in Neurology. 2022-01-01
40 citations
Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses.
Natalia Palacios, Karl Münger, Kathryn C. Fitzgerald, Jaime E. Hart, Tanuja Chitnis
Environment International. 2017-12-01

Journal Articles

Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Tanuja Chitnis, Nancy L Sicotte, JAMA Neurology
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Jerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine

Press Mentions

Alzheimer’s Vaccine: Nasal Spray Trial Shows Promise, Researchers SayDecember 2nd, 2022
Tiziana Starts Enrolment in Secondary Progressive MS Expanded Access ProgrammeOctober 27th, 2022
16 People Are About to Help Test This Nasal Vaccine for Alzheimer’sMay 17th, 2022
Join now to see all

Committees

Board Member, ACTRIMS - Americas Committee for Treatment and Research in MS 2020 - Present
Board Member, National Multiple Sclerosis Clinical Advisory Committee 2019 - Present
Chair, International Pediatric Multiple Sclerosis Study Group (IPMSSG) 2010 - 2018

Professional Memberships

American Academy of Neurology - AAN
Member

Other Languages

French, Marathi